Stephen R. Brady

Insider Reports History

Location
Seattle, WA
Signature
/s/ Nicholas Maestas, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen R. Brady:

Company Role Class Num Shares Value Price $ Report Date Ownership
Tempest Therapeutics, Inc. President and CEO, Director Common Stock 46,376 $97,853 $2.11 03 Jul 2024 Direct
Tempest Therapeutics, Inc. President and CEO, Director Employee Stock Option (right to buy) 550,000 02 Jan 2025 Direct
Atreca, Inc. Director Stock Option (right to buy) 12,000 13 Jun 2023 Direct

Insider Reports Filed by Stephen R. Brady

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TPST Tempest Therapeutics, Inc. 02 Jan 2025 1 $0 4 President and CEO, Director 06 Jan 2025, 17:00
TPST Tempest Therapeutics, Inc. 03 Jul 2024 1 +$73,850 4 President and CEO, Director 08 Jul 2024, 16:15
TPST Tempest Therapeutics, Inc. 03 Jan 2024 1 $0 4 President and CEO, Director 05 Jan 2024, 16:41
TPST Tempest Therapeutics, Inc. 11 Oct 2023 1 $0 4 President and CEO, Director 13 Oct 2023, 16:41
/report/000120919123037517-brady-stephen-r-2023-06-13 Atreca, Inc. 13 Jun 2023 1 $0 4 Director 15 Jun 2023, 18:06
TPST Tempest Therapeutics, Inc. 03 Jan 2023 1 $0 4 Chief Executive Officer, Director 05 Jan 2023, 19:00
TPST Tempest Therapeutics, Inc. 21 Jun 2022 1 $0 4 Chief Executive Officer, Director 22 Jun 2022, 16:29
/report/000120919122036107-brady-stephen-r-2022-06-08 Atreca, Inc. 08 Jun 2022 1 $0 4 Director 10 Jun 2022, 18:46
TPST Tempest Therapeutics, Inc. 04 Jan 2022 1 $0 4 Chief Executive Officer, Director 06 Jan 2022, 18:23
/report/000120919121047021-brady-stephen-r-2021-07-14 Atreca, Inc. 14 Jul 2021 1 $0 4 Director 16 Jul 2021, 19:39
/report/000120919121047019-brady-stephen-r-2021-07-14 Atreca, Inc. 14 Jul 2021 0 $0 3 Director 16 Jul 2021, 19:36
TPST Millendo Therapeutics, Inc. 25 Jun 2021 4 $0 4 Chief Executive Officer, Director 29 Jun 2021, 21:54
TPST Millendo Therapeutics, Inc. 25 Jun 2021 0 $0 3 Chief Executive Officer, Director 29 Jun 2021, 21:25